What Researchers Did
Researchers conducted an observational study on 80 patients with chronic refractory foot osteomyelitis, treating them with surgical debridement, tailored antibiotics, and hyperbaric oxygen therapy (HBOT).
What They Found
Of the 80 patients, 68 (85%) achieved complete infection clearance. This clearance was maintained over a mean follow-up of 36 months, with no HBOT-induced complications reported.
What This Means for Canadian Patients
Canadian patients suffering from chronic foot osteomyelitis might benefit from hyperbaric oxygen therapy as an adjunct to standard surgical and antibiotic treatments. This approach could lead to higher rates of infection clearance and improved long-term outcomes for a difficult-to-treat condition.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As an observational study, it lacks a control group and the abstract indicates a need for further extensive research.